-2%
Topmate is prescribed as:
Epilepsy:
- For adults and children aged 6 years and older who have been newly diagnosed with epilepsy, specifically for the treatment of generalized tonic-clonic seizures or partial seizures (with or without secondary generalization).
- For adults and children over 2 years old whose partial seizures (with or without secondary generalization) are not adequately managed by conventional first-line antiepileptic drugs. It is also indicated for seizures associated with Lennox-Gastaut Syndrome and primary generalized tonic-clonic seizures.
Migraine:
Topmate is approved for migraine prophylaxis in adults. Prophylactic treatment may be considered under the following conditions:
- Patients experience three or more migraine episodes per month.
- Frequent migraines that significantly disrupt daily activities.
A seizure results from an abnormal and uncontrolled electrical discharge in the brain, causing a temporary disruption in brain function. This can manifest as impaired alertness, unusual sensations, focal involuntary movements, or convulsions. Common seizure types include tonic-clonic seizures and partial-onset seizures.
The precise mechanisms by which topiramate exerts its effects on seizures and migraines remain incompletely understood. However, several properties of this medication likely contribute to its therapeutic benefits. Topiramate impacts various neural pathways, including voltage-dependent sodium channels, GABA receptors, and glutamate receptors.
GABA and Glutamate Modulation:
- Topiramate enhances GABA-A receptor activity at brain non-benzodiazepine receptor sites. GABA-A receptors are typically inhibitory, helping to suppress neuronal activity.
- It also inhibits glutamate activity at AMPA and kainate receptors, which are normally excitatory.
- By increasing inhibitory (GABA) activity and reducing excitatory (glutamate) activity, topiramate reduces neuronal excitability, effectively preventing seizures and migraine episodes.
Voltage-Dependent Sodium Channel Blocking:
- Topiramate blocks voltage-dependent sodium channels, which further prevents the propagation of seizure activity.
Carbonic Anhydrase Inhibition:
- Topiramate inhibits certain carbonic anhydrase isozymes. While the clinical significance of this action remains unclear, it may contribute to its pharmacological profile.